Characterization of VIM, VEB and CTX-M Beta-lactamase Gene in Escherichia coli and Pseudomonas aeruginosa Isolated from Urine Samples of Patients Visiting a Tertiary Hospital in Abakaliki

Author:

Ilang Donatus ChukwumaORCID,Peter Ikemesit UdemeORCID,Iroha Ifeanyichukwu RomanusORCID

Abstract

The spread and convergence of multiple beta-lactamase genes across distinct resistant bacterial populations from various hosts and settings demonstrates increased risk of morbidity and mortality in humans. This study was undertaken to characterize blaVIM, blaVEB and blaCTX-M beta-lactamase gene in Escherichia coli and P. aeruginosa isolates from patients visiting a tertiary hospital in Abakaliki. A total of three hundred (300) urine samples were collected from patients and were subjected to bacteriological examination using culture, Gram staining and biochemical technique, for routine microbiological identification and further confirmed using the VITEK-2 Automated System (Biomerieux, France). Antimicrobial susceptibility studies were determined using the Kirby–Bauer disk diffusion method. All isolate were further screen for various beta-lactamase resistant gene by PCR using specific primer. Of the 300 urine samples collected, prevalence rate of 187 (62.3%) and 91 (30.3 %) E. coli and P. aeruginosa were recorded. The isolates exhibited 50.0-100% percentage of resistance to Amoxycillin-Clavulanic acid, Azetronam, Cefoxitin, Ceftriaxone and Piperacillin/tazobactam. The proportion of beta-lactamase gene in E. coli were as follows (VEB 143/76.5 %; CTX-M 175/93.5 %; VIM 77/41.2 %) while beta-lactamase gene in P. aeruginosa were as follows (VEB 91/100 %; CTX-M 63/69.2%; VIM 48/52.7 %). The presence of these gene in our study indicates the possibility of therapeutic failure, serious consequences for infection control and increased risk of morbidity and mortality in patients. Hence, continuous effort in hospital surveillance, infection control, and clinical audits must be conducted to fight against the rapid development and spread of antibiotic-resistant bacteria pathogens. Keywords: Beta-lactamase, Escherichia coli, Pseudomonas aeruginosa, VIM, VEB, CTX-M

Publisher

Society of Pharmaceutical Tecnocrats

Reference31 articles.

1. Yusof, N.Y., Norazzman, N.I.I., Hakim, S.N. W. A., Azlan, M.M., Anthony, A.A., Mustafa, F.H., Ahmed, N., Rabaan, A.A., Almuthree, S.A., Alawfi, A. Prevalence of Mutated Colistin-Resistant Klebsiella pneumoniae: A Systematic Review and Meta Analysis. Tropical Medicine and Infectious Disease, 7:414-419. https://doi.org/10.3390/tropicalmed7120414 PMid:36548669 PMCid:PMC9782491

2. Ogba, R. C., Nomeh, O. L, Edemekong, C. I., Nwuzo, A. C., Akpu, P. O., Peter, I. U and Iroha, I. R. Molecular Characterization of Carbapenemase Encoding Genes in Pseudomonas aeruginosa from Tertiary Healthcare in South Eastern Nigeria. Asian Journal of Biology, Genetic and Molecular Biology, 2022;12(4):161-168. https://doi.org/10.9734/ajbgmb/2022/v12i4281

3. Nomeh, L. O., Federica, O. I., Joseph, O. V., Moneth, E. C., Ogba, R. C., Nkechi, O. A., Peter, I. U., Akpu, P. O., Edemekong, C. I and Iroha, I. R. Detection of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae Implicated in Urinary Tract Infection. Asian Journal of Research in Infectious Diseases, 2023;2 (1):15-23. https://doi.org/10.9734/ajrid/2023/v12i1234

4. Mustafai, M. M., Hafeez, M., Munawar, S., Basha, S., Rabaan, A. A., Halwani, M. A., Alawfi, A., Alshengeti, A., Najim, M. A and Alwarthan, S. Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional Study. Antibiotics, 2023;12:148-149 https://doi.org/10.3390/antibiotics12010148 PMid:36671350 PMCid:PMC9854900

5. Egwu, E., Ibiam, F. A, Moses, I. B., Iroha, C. S Orji, I., Okafor-Alu, F. N., Eze, C. O and Iroha, I. R. Antimicrobial Susceptibility and Molecular Characteristics of Beta-lactam- and Fluoroquinolone-resistant E. coli from Human Clinical Samples in Nigeria. Scientific African 2023;21:18-63 https://doi.org/10.1016/j.sciaf.2023.e01863

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3